VEGFA and choroidal neovascularization: Randomized clinical trials and real-life experiences have demonstrated, that intravitreal injection (IVI) of anti-vascular endothelial growth factor (anti-VEGF) can effectively and safely control choroidal neovascularization (CNV) and exudation, thus maintaining visual acuity [2].